DiaSorin Molecular LLC
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$3.2M
Doctors Paid
11
Transactions
109
2024 Total
$1.2M
Payment Breakdown by Category
Research$3.0M (94.6%)
Consulting$47,725 (1.5%)
Travel$8,434 (0.3%)
Food & Beverage$1,476 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3.0M | 50 | 94.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $89,960 | 12 | 2.8% |
| Consulting Fee | $47,725 | 9 | 1.5% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $9,884 | 5 | 0.3% |
| Travel and Lodging | $8,434 | 16 | 0.3% |
| Space rental or facility fees (teaching hospital only) | $5,100 | 3 | 0.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $5,000 | 1 | 0.2% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $2,000 | 1 | 0.1% |
| Food and Beverage | $1,476 | 12 | 0.0% |
Payments by Type
Research
$3.0M
50 transactions
General
$169,579
59 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| NES Flu A/B & COVID-19 Clinical Study (Project DD20-012) | $1.0M | 0 | 3 |
| NES Flu A/B (Project DD20-012) Clinical Study | $740,155 | 0 | 2 |
| C. Auris IVD Clinical Study (Project DD20-009) Clinical Study | $497,042 | 0 | 2 |
| DD18-033 Simplexa Congenital CMV | $141,933 | 0 | 7 |
| Simplexa COVID-19 Direct: Saliva/NPS Matched Pair Specimen Evaluation - PROT.711.00593 (DD20-008 COVID-19) | $82,130 | 0 | 2 |
| Pre-Market IVD Device Study for Simplexa Atypical Pneumonia Direct (DD17-004 Atypical Pn) | $78,576 | 0 | 1 |
| Simplexa GBS Direct | $75,924 | 0 | 5 |
| Simplexa Bordetella Direct | $59,852 | 0 | 4 |
| Flu/COVID Miniflex Clinical Study | $51,945 | 0 | 1 |
| Simplexa Congenital CMV Direct: Reproducibility - PROT.711.00478 (DD18-033) | $35,275 | 0 | 1 |
| C. Auris IVD Clinical Study (Project DD20-009) | $24,550 | 0 | 1 |
| Evaluation of Investigational Simplexa EV & HPeV Direct Assay in Cerebral Spinal Fluid Specimens | $16,050 | 0 | 1 |
| Simplexa COVID-19 & Flu A/B Direct - PROT.711.00586 (DD20-017) | $15,680 | 0 | 1 |
| Evaluation of Simplexa Enterco/Parechovirus Direct | $14,125 | 0 | 1 |
| DD17-004 Atypical Pneumoniae Direct | $13,000 | 0 | 2 |
| Simplexa VZV Swab Direct | $12,970 | 0 | 1 |
| Bordetella Beta Testing | $12,500 | 0 | 1 |
| VZV Infection in Cerebrospinal Fluid | $12,476 | 0 | 1 |
| Simplexa Congenital CMV Clinical Study | $11,669 | 0 | 2 |
| A Multi-Site Clinical Evaluation of the LIAISON NES Group A Strep (GAS) Assay in Symptomatic Patients (Project DD22-001) | $10,395 | 0 | 1 |
| Study Protocol Simplexa Atypical Pneumonia Direct: Clinical Agreement for 510(k) PROT.711.00471 (DD17-004) | $10,300 | 0 | 1 |
| Performance Comparison Bordetella Assay | $9,880 | 0 | 1 |
| Simplexa Clostridium difficile direct clinical study | $8,831 | 0 | 1 |
| Simplexa VZV Direct: CSF & Swabs | $6,250 | 0 | 1 |
| Simplexa GBS Direct Comparison | $2,894 | 0 | 1 |
| Performance Comparison & Workflow Evaluation of Simplexa Bordetella Direct with DiaSorin Molecular Real Time PCR Bordeteella pertussis and parapertussis | $2,130 | 0 | 1 |
| Performance Comparison & Workflow Evaluation of Simplexa GBS Direct | $2,000 | 0 | 1 |
| Group B Strep Carrot Broth Evaluation | $615.00 | 0 | 1 |
Payments by Medical Specialty
| Specialty | Total Paid | Doctors | Avg/Doctor |
|---|---|---|---|
| Clinical Pathology/Laboratory Medicine | $26,899 | 1 | $26,899 |
| Critical Care Medicine | $16,700 | 2 | $8,350 |
| Pediatric Infectious Diseases | $9,275 | 2 | $4,638 |
| Developmental - Behavioral Pediatrics | $7,683 | 1 | $7,683 |
| Rheumatology | $5,000 | 1 | $5,000 |
| Pediatric Gastroenterology | $4,400 | 1 | $4,400 |
| Anatomic Pathology & Clinical Pathology | $2,021 | 1 | $2,021 |
| Internal Medicine | $1,036 | 1 | $1,036 |
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2022 |
|---|---|---|---|---|
| Dr. Neil Anderson, Md, MD | Clinical Pathology/Laboratory Medicine | Rochester, MN | $26,899 | $0 |
| Samuel Dominguez, Md, MD | Pediatric Infectious Diseases | Aurora, CO | $9,200 | $0 |
| Chadi Hage, M.d, M.D | Critical Care Medicine | Pittsburgh, PA | $9,200 | $0 |
| Dr. Megan Pesch, M.d, M.D | Developmental - Behavioral Pediatrics | Ann Arbor, MI | $7,683 | $0 |
| Michael Niederman, Md, MD | Critical Care Medicine | New York, NY | $7,500 | $0 |
| Dr. Philip Molloy, Md, MD | Rheumatology | Plymouth, MA | $5,000 | $0 |
| Benjamin Gold, M.d, M.D | Pediatric Gastroenterology | Atlanta, GA | $4,400 | $0 |
| Dr. Walther Pfeifer, M.d, M.D | Anatomic Pathology & Clinical Pathology | Boston, MA | $2,021 | $0 |
| Dr. Jody Thompson, M.d, M.D | Internal Medicine | Fargo, ND | $1,036 | $0 |
| Dr. Ingrid Camelo, Md, MD | Pediatric Infectious Diseases | Augusta, GA | $75.05 | $0 |
| Unknown Provider | — | — | $66.56 | $0 |
Ad
Top Products
- NES Flu A/B & COVID-19 $1.0M
- NES Flu A/B $740,155
Associated Products (11)
- NES Flu A/B & COVID-19 $1.0M
- NES Flu A/B $740,155
- C. Auris $483,589
- Simplexa Atypical Pneumonia Direct $98,876
- Simplexa COVID-19 Direct $82,130
- Flu/COVID Miniflex $51,945
- Simplexa C. auris Direct $38,003
- Simplexa Congenital CMV Direct $35,275
- Simplexa COVID-19 & Flu A/B Direct $15,680
- Simplexa Congenital CMV $13,169
- LIAISON NES Group A Strep $10,395
Payment Categories
- Food & Beverage $1,476
- Consulting $47,725
- Travel & Lodging $8,434
- Research $3.0M
About DiaSorin Molecular LLC
DiaSorin Molecular LLC has made $3.2M in payments to 11 healthcare providers, recorded across 109 transactions in the CMS Open Payments database. In 2024, the company paid $1.2M. The top product by payment volume is NES Flu A/B & COVID-19 ($1.0M).
Payments were distributed across 8 medical specialties. The top specialty by payment amount is Clinical Pathology/Laboratory Medicine ($26,899 to 1 doctors).
Payment categories include: Food & Beverage ($1,476), Consulting ($47,725), Research ($3.0M), Travel & Lodging ($8,434).
DiaSorin Molecular LLC is associated with 11 products in the CMS Open Payments database, including NES Flu A/B & COVID-19, NES Flu A/B, and C. Auris.